These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4395050)

  • 1. Some problems encountered in attempting to estimate catecholamine turnover using lbbelled tyrosine.
    Persson T; Waldeck B
    J Pharm Pharmacol; 1970 Jul; 22(7):473-8. PubMed ID: 4395050
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 3. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO; Hamberger B; Jonsson G
    J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons.
    Thierry AM; Blanc G; Glowinski J
    Eur J Pharmacol; 1971 May; 14(3):303-7. PubMed ID: 4405541
    [No Abstract]   [Full Text] [Related]  

  • 5. Catecholamine turnover in rat cerebral cortex and caudate following repeated treatment with dihydroergotoxine.
    Cvejić V; Mrsulja BB
    Gerontology; 1981; 27(1-2):7-12. PubMed ID: 6111518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmitter-dependent changes of equilibrium characteristics of catecholamine synaptosomes in sucrose density gradients.
    Pycock C; Jonsson G
    Med Biol; 1974 Aug; 52(4):260-8. PubMed ID: 4371596
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the regional biosynthesis and metabolism of catecholamines in the central nervous system of the monkey.
    Goldstein M; Anagnoste B; Owen WS; Battista AF
    Experientia; 1967 Feb; 23(2):98-9. PubMed ID: 4382238
    [No Abstract]   [Full Text] [Related]  

  • 8. An ontogenic study on the effect of catecholamine receptor-stimulating agents on the turnover of noradrenaline and dopamine in the brain.
    Kellogg C; Wennerström G
    Brain Res; 1974 Oct; 79(3):451-64. PubMed ID: 4371328
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cold exposure on catecholamine depleting actions of hydroxylase inhibitors.
    Chan WC; Johnson GE
    Eur J Pharmacol; 1968 Apr; 3(1):40-6. PubMed ID: 5654668
    [No Abstract]   [Full Text] [Related]  

  • 11. Presence of dopaminergic terminals and absence of dopaminergic cell bodies in the cerebral cortex of the cat.
    Thierry AM; Hirsch JC; Tassin JP; Blanc G; Glowinski J
    Brain Res; 1974 Oct; 79(1):77-88. PubMed ID: 4425954
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.
    Brodie BB; Costa E; Dlabac A; Neff NH; Smookler HH
    J Pharmacol Exp Ther; 1966 Dec; 154(3):493-8. PubMed ID: 5928249
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on catecholamine synthesis in the spontaneously hypertensive rat: catecholamine synthesis in the central nervous system.
    Yamabe H; De Jong W; Lovenberg W
    Eur J Pharmacol; 1973 Apr; 22(1):91-8. PubMed ID: 4145256
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of the intraventricular injection of 6-hydroxydopamine. I. On the cerebral monoamines of the cat].
    Petitjean F; Laguzzi R; Sordet F; Jouvet M; Pujol JF
    Brain Res; 1972 Dec; 48():281-93. PubMed ID: 4645209
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain.
    Persson T; Waldeck B
    Eur J Pharmacol; 1970; 11(3):315-20. PubMed ID: 5477308
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of ventromedial tegmental lesions on the disposition of dopamine in the caudate nucleus of the monkey.
    Goldstein M; Anagnoste B; Owen WS; Battista AF
    Brain Res; 1967 Mar; 4(2):298-300. PubMed ID: 4961813
    [No Abstract]   [Full Text] [Related]  

  • 17. Minor tranquillizers, stress and central catecholamine neurons.
    Corrodi H; Fuxe K; Lidbrink P; Olson L
    Brain Res; 1971 Jun; 29(1):1-16. PubMed ID: 5564261
    [No Abstract]   [Full Text] [Related]  

  • 18. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 19. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
    Andén NE; Fuxe K
    Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the role of brain catecholamines in motor activity: experiments with inhibitors of synthesis and of monoamine oxidase.
    Svensson TH; Waldeck B
    Psychopharmacologia; 1970; 18(4):357-65. PubMed ID: 5491473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.